Oh_老虎社区_美港股上老虎

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":876746497,"tweetId":"876746497","gmtCreate":1637369438439,"gmtModify":1637369438746,"author":{"id":3575713608628103,"idStr":"3575713608628103","authorId":3575713608628103,"authorIdStr":"3575713608628103","name":"oypsamuel","avatar":"https://static.tigerbbs.com/445c12ed45a5bbfc273f2a9ae6b7adce","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":16,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","extraTitle":"","html":"<html><head></head><body>Oh</body></html>","htmlText":"<html><head></head><body>Oh</body></html>","text":"Oh","highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/876746497","repostId":1147615281,"repostType":4,"repost":{"id":"1147615281","kind":"news","pubTimestamp":1637364985,"share":"https://www.laohunote.com/m/news/1147615281?lang=zh_CN&edition=full","pubTime":"2021-11-20 07:36","market":"us","language":"en","title":"Pfizer Stock Leaps, Moderna Surges As FDA Approves Adult COVID Booster Shots<blockquote>随着 FDA 批准成人新冠加强注射，辉瑞股价飙升，Moderna 股价飙升</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1147615281","media":"The Street","summary":"The Food & Drug Administration approved booster shots of both the Pfizer and Moderna Covid vaccines ","content":"The Food &amp; Drug Administration approved booster shots of both the Pfizer and Moderna Covid vaccines for all American adults Friday.<blockquote>美国食品和药物管理局周五批准为所有美国成年人注射辉瑞和Moderna Covid疫苗的加强针。</blockquote> $Pfizer Inc&nbsp;(PFE)$ shares jumped higher Friday, while $Moderna&nbsp;(MRNA)$&nbsp;surged alongside it, after the U.S. Food &amp; Drug Administration approved the use of their Covid booster shots in all American adults.<blockquote>$辉瑞公司（PFE)$ 股价周五上涨，而 $Moderna (MRNA在美国食品和药物管理局批准在所有美国成年人中使用新冠加强注射后，)$ 也随之飙升。</blockquote> The booster dose, the FDA said, can come six months after the completion of the two-shot series of both the Pfizer and Moderna vaccines following a review of&nbsp;Emergency Use Authorization approvals for both drugmakers.&nbsp;The FDA approved Pfizer's COVID vaccine, known as 'Comiranty', for booster shots inolder and at risk Americans in late September, one month after asimilar nod for Moderna's in&nbsp;immunocompromised individuals.<blockquote>美国食品和药物管理局表示，在对两家制药商的紧急使用授权批准进行审查后，加强剂量可以在辉瑞和Moderna疫苗的两针系列完成六个月后进行。美国食品和药物管理局于9月下旬批准辉瑞的COVID疫苗，被称为“Comiranty”，用于老年和高危美国人的加强注射，一个月前，Moderna的疫苗在免疫功能低下的个体中获得了类似的批准。</blockquote> A panel advising the Centers for Disease Control and Prevention will meet later Friday to assess the booster shot application as President Joe Biden continues to push for broader take-up of the vaccines heading into the winter months.<blockquote>一个为疾病控制和预防中心提供建议的小组将于周五晚些时候召开会议，评估加强注射的应用，因为乔·拜登总统继续推动疫苗在冬季的更广泛使用。</blockquote> That move followed a dire warning from outgoing German Chancellor Angela Merkel, who called the Covid situation \"dramatic\" as infections surge and fatalities rise.<blockquote>此前，即将卸任的德国总理安格拉·默克尔发出了可怕的警告，她称随着感染人数激增和死亡人数上升，新冠疫情形势“严峻”。</blockquote> The lockdown, as well as fresh restrictions on movement and businesses in Germany, pushed the euro to a mid-July low of 1.1289 against the U.S. dollar and clipped bets on near-term energy demand in the world's biggest economic bloc.<blockquote>封锁以及德国对行动和商业的新限制，将欧元兑美元汇率推至 7 月中旬的低点 1.1289，并削减了对这个全球最大经济集团近期能源需求的押注。</blockquote> “As we near the two-year mark in our fight against COVID-19, we have reached another critical milestone with the expanded authorization of a booster dose of our COVID-19 vaccine in individuals 18 years and older,” said Pfizer CEO Albert Bourla. “With boosters, more adults will now have the opportunity to help preserve a high-level of protection against this disease. We are grateful to the FDA for their rigorous review, and the action taken today that we hope will help accelerate our path out of this pandemic.”<blockquote>“辉瑞公司首席执行官阿尔伯特-布尔拉（Albert Bourla）说：”随着我们在抗击 COVID-19 的斗争中接近两年，随着 COVID-19 疫苗在 18 岁及以上人群中的加强剂量授权扩大，我们又达到了一个重要的里程碑。“有了加强剂，更多的成年人现在将有机会帮助保持对这种疾病的高水平保护。我们感谢美国食品及药物管理局的严格审查，我们希望今天采取的行动将有助于加快我们摆脱这一大流行病的步伐”。</blockquote> Earlier this week, Pfizer agreed to sell 10 million doses of its developing Covid antiviral pill Paxlovid,&nbsp;which is currently being reviewed for Emergency Use Approval by the FDA, to the United States Department of Health and Human Services for around $5.3 billion.<blockquote>本周早些时候，辉瑞公司同意以约53亿美元的价格向美国卫生与公众服务部出售1000万剂其正在开发的Covid抗病毒药丸Paxlovid，该药丸目前正在接受FDA的紧急使用批准审查。</blockquote> At $530 per tablet, the cost is around 25% cheaper than the $700 price agreed with Merck &amp; Co.&nbsp;(MRK)&nbsp;last month to buy1.7 million doses its 'molnupiravir' treatmentof \"mild-to-moderate Covid in adults who are at risk for progressing to severe forms of disease, or hospitalization.<blockquote>每片药片售价 530 美元，比与默克公司商定的 700 美元价格便宜约 25%（MRK) 上个月购买了 170 万剂其“莫努匹拉韦”治疗“轻度至中度新冠肺炎”的成年人，这些成年人有发展为严重疾病或住院的风险。</blockquote>","source":"lsy1610613172068","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Stock Leaps, Moderna Surges As FDA Approves Adult COVID Booster Shots<blockquote>随着 FDA 批准成人新冠加强注射，辉瑞股价飙升，Moderna 股价飙升</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Stock Leaps, Moderna Surges As FDA Approves Adult COVID Booster Shots<blockquote>随着 FDA 批准成人新冠加强注射，辉瑞股价飙升，Moderna 股价飙升</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nThe Street2021-11-20 07:36\n\n</h4>\n</header>\n<article>\nThe Food &amp; Drug Administration approved booster shots of both the Pfizer and Moderna Covid vaccines for all American adults Friday.<blockquote>美国食品和药物管理局周五批准为所有美国成年人注射辉瑞和Moderna Covid疫苗的加强针。</blockquote> $Pfizer Inc&nbsp;(PFE)$ shares jumped higher Friday, while $Moderna&nbsp;(MRNA)$&nbsp;surged alongside it, after the U.S. Food &amp; Drug Administration approved the use of their Covid booster shots in all American adults.<blockquote>$辉瑞公司（PFE)$ 股价周五上涨，而 $Moderna (MRNA在美国食品和药物管理局批准在所有美国成年人中使用新冠加强注射后，)$ 也随之飙升。</blockquote> The booster dose, the FDA said, can come six months after the completion of the two-shot series of both the Pfizer and Moderna vaccines following a review of&nbsp;Emergency Use Authorization approvals for both drugmakers.&nbsp;The FDA approved Pfizer's COVID vaccine, known as 'Comiranty', for booster shots inolder and at risk Americans in late September, one month after asimilar nod for Moderna's in&nbsp;immunocompromised individuals.<blockquote>美国食品和药物管理局表示，在对两家制药商的紧急使用授权批准进行审查后，加强剂量可以在辉瑞和Moderna疫苗的两针系列完成六个月后进行。美国食品和药物管理局于9月下旬批准辉瑞的COVID疫苗，被称为“Comiranty”，用于老年和高危美国人的加强注射，一个月前，Moderna的疫苗在免疫功能低下的个体中获得了类似的批准。</blockquote> A panel advising the Centers for Disease Control and Prevention will meet later Friday to assess the booster shot application as President Joe Biden continues to push for broader take-up of the vaccines heading into the winter months.<blockquote>一个为疾病控制和预防中心提供建议的小组将于周五晚些时候召开会议，评估加强注射的应用，因为乔·拜登总统继续推动疫苗在冬季的更广泛使用。</blockquote> That move followed a dire warning from outgoing German Chancellor Angela Merkel, who called the Covid situation \"dramatic\" as infections surge and fatalities rise.<blockquote>此前，即将卸任的德国总理安格拉·默克尔发出了可怕的警告，她称随着感染人数激增和死亡人数上升，新冠疫情形势“严峻”。</blockquote> The lockdown, as well as fresh restrictions on movement and businesses in Germany, pushed the euro to a mid-July low of 1.1289 against the U.S. dollar and clipped bets on near-term energy demand in the world's biggest economic bloc.<blockquote>封锁以及德国对行动和商业的新限制，将欧元兑美元汇率推至 7 月中旬的低点 1.1289，并削减了对这个全球最大经济集团近期能源需求的押注。</blockquote> “As we near the two-year mark in our fight against COVID-19, we have reached another critical milestone with the expanded authorization of a booster dose of our COVID-19 vaccine in individuals 18 years and older,” said Pfizer CEO Albert Bourla. “With boosters, more adults will now have the opportunity to help preserve a high-level of protection against this disease. We are grateful to the FDA for their rigorous review, and the action taken today that we hope will help accelerate our path out of this pandemic.”<blockquote>“辉瑞公司首席执行官阿尔伯特-布尔拉（Albert Bourla）说：”随着我们在抗击 COVID-19 的斗争中接近两年，随着 COVID-19 疫苗在 18 岁及以上人群中的加强剂量授权扩大，我们又达到了一个重要的里程碑。“有了加强剂，更多的成年人现在将有机会帮助保持对这种疾病的高水平保护。我们感谢美国食品及药物管理局的严格审查，我们希望今天采取的行动将有助于加快我们摆脱这一大流行病的步伐”。</blockquote> Earlier this week, Pfizer agreed to sell 10 million doses of its developing Covid antiviral pill Paxlovid,&nbsp;which is currently being reviewed for Emergency Use Approval by the FDA, to the United States Department of Health and Human Services for around $5.3 billion.<blockquote>本周早些时候，辉瑞公司同意以约53亿美元的价格向美国卫生与公众服务部出售1000万剂其正在开发的Covid抗病毒药丸Paxlovid，该药丸目前正在接受FDA的紧急使用批准审查。</blockquote> At $530 per tablet, the cost is around 25% cheaper than the $700 price agreed with Merck &amp; Co.&nbsp;(MRK)&nbsp;last month to buy1.7 million doses its 'molnupiravir' treatmentof \"mild-to-moderate Covid in adults who are at risk for progressing to severe forms of disease, or hospitalization.<blockquote>每片药片售价 530 美元，比与默克公司商定的 700 美元价格便宜约 25%（MRK) 上个月购买了 170 万剂其“莫努匹拉韦”治疗“轻度至中度新冠肺炎”的成年人，这些成年人有发展为严重疾病或住院的风险。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.thestreet.com/markets/pfizer-stock-leaps-moderna-surges-as-fda-approves-covid-boosters\">The Street</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","PFE":"辉瑞"},"source_url":"https://www.thestreet.com/markets/pfizer-stock-leaps-moderna-surges-as-fda-approves-covid-boosters","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1147615281","content_text":"The Food & Drug Administration approved booster shots of both the Pfizer and Moderna Covid vaccines for all American adults Friday.\n$Pfizer Inc (PFE)$ shares jumped higher Friday, while $Moderna (MRNA)$ surged alongside it, after the U.S. Food & Drug Administration approved the use of their Covid booster shots in all American adults.\nThe booster dose, the FDA said, can come six months after the completion of the two-shot series of both the Pfizer and Moderna vaccines following a review of Emergency Use Authorization approvals for both drugmakers. The FDA approved Pfizer's COVID vaccine, known as 'Comiranty', for booster shots inolder and at risk Americans in late September, one month after asimilar nod for Moderna's in immunocompromised individuals.\nA panel advising the Centers for Disease Control and Prevention will meet later Friday to assess the booster shot application as President Joe Biden continues to push for broader take-up of the vaccines heading into the winter months.\nThat move followed a dire warning from outgoing German Chancellor Angela Merkel, who called the Covid situation \"dramatic\" as infections surge and fatalities rise.\nThe lockdown, as well as fresh restrictions on movement and businesses in Germany, pushed the euro to a mid-July low of 1.1289 against the U.S. dollar and clipped bets on near-term energy demand in the world's biggest economic bloc.\n“As we near the two-year mark in our fight against COVID-19, we have reached another critical milestone with the expanded authorization of a booster dose of our COVID-19 vaccine in individuals 18 years and older,” said Pfizer CEO Albert Bourla. “With boosters, more adults will now have the opportunity to help preserve a high-level of protection against this disease. We are grateful to the FDA for their rigorous review, and the action taken today that we hope will help accelerate our path out of this pandemic.”\nEarlier this week, Pfizer agreed to sell 10 million doses of its developing Covid antiviral pill Paxlovid, which is currently being reviewed for Emergency Use Approval by the FDA, to the United States Department of Health and Human Services for around $5.3 billion.\nAt $530 per tablet, the cost is around 25% cheaper than the $700 price agreed with Merck & Co. (MRK) last month to buy1.7 million doses its 'molnupiravir' treatmentof \"mild-to-moderate Covid in adults who are at risk for progressing to severe forms of disease, or hospitalization.","news_type":1,"symbols_score_info":{"MRNA":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":1095,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":2,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/876746497"}